Intravenous Busulfan, Dimethylacetamide and neurotoxicity after high-dose pretransplant conditioning chemotherapy

被引：0
|
作者：
Ramdial, J. [1 ]
Chan, K. H. [1 ]
Sanchez Petitto, G. [1 ]
Valdez, B. [1 ]
Andersson, B. S. [1 ]
Nieto, Y. [1 ]
机构：
[1] UT MD Anderson Canc Ctr, Dept Stem Cell Transplantat & Cellular Therapy, Houston, TX 77030 USA
来源：
BONE MARROW TRANSPLANTATION | 2023年 / 58卷 / 06期
关键词：
STEM-CELL TRANSPLANTATION; TOTAL-BODY IRRADIATION; DAILY IV-BUSULFAN; VENOOCCLUSIVE DISEASE; FLUDARABINE; CYCLOPHOSPHAMIDE; REGIMEN; GEMCITABINE; MELPHALAN; TOXICITY;
D O I：
10.1038/s41409-023-01964-y
中图分类号：
Q6 [生物物理学];
学科分类号：
071011 ;
摘要：
引用
收藏
页码：635 / 638
页数：4
相关论文
共 50 条
  • [41] High-dose chemotherapy in childhood brain tumors
    Wolff, JEA
    Finlay, JL
    ONKOLOGIE, 2004, 27 (03): : 239 - 245
  • [42] Thiotepa, busulfan, and cyclophosphamide or busulfan, cyclophosphamide, and etoposide high-dose chemotherapy followed by autologous stem cell transplantation for consolidation of primary central nervous system lymphoma
    Jaewon Hyung
    Jung Yong Hong
    Dok Hyun Yoon
    Shin Kim
    Jung Sun Park
    Chan-sik Park
    Sang-wook Lee
    Jeong Hoon Kim
    Jin Sook Ryu
    Jooryung Huh
    Cheolwon Suh
    Annals of Hematology, 2019, 98 : 1657 - 1664
  • [43] High-dose chemotherapy in childhood brain tumours
    C. Kalifa
    Dominique Valteau
    Barry Pizer
    Gilles Vassal
    Jacques Grill
    Olivier Hartmann
    Child's Nervous System, 1999, 15 : 498 - 505
  • [44] Evaluation of pretransplant factors predicting cardiac dysfunction following high-dose melphalan conditioning and autologous peripheral blood stem cell transplantation
    Bleeker, Jonathan S.
    Gertz, Morie A.
    Pellikka, Patricia A.
    Larson, Dirk R.
    Buadi, Francis
    Dingli, David
    Dispenzieri, Angela
    Hayman, Suzanne R.
    Hogan, William
    Kumar, Shaji
    Rajkumar, S. Vincent
    Lacy, Martha Q.
    EUROPEAN JOURNAL OF HAEMATOLOGY, 2012, 89 (03) : 228 - 235
  • [45] Busulfan pharmacokinetics following intravenous and oral dosing regimens in children receiving high-dose myeloablative chemotherapy for high-risk neuroblastoma as part of the HR-NBL-1/SIOPEN trial
    Veal, G. J.
    Nguyen, L.
    Paci, A.
    Riggi, M.
    Amiel, M.
    Valteau-Couanet, D.
    Brock, P.
    Ladenstein, R.
    Vassal, G.
    EUROPEAN JOURNAL OF CANCER, 2012, 48 (16) : 3063 - 3072
  • [46] Pharmacokinetics of high-dose carboplatin in children undergoing high-dose chemotherapy and autologous stem cell transplantation with BSA-based dosing
    Hong, Che Ry
    Kang, Hyoung Jin
    Moon, Seol Ju
    Oh, Jaeseong
    Hong, Kyung Taek
    Choi, Jung Yoon
    Yu, Kyung-Sang
    Shin, Hee Young
    BONE MARROW TRANSPLANTATION, 2020, 55 (01) : 137 - 146
  • [47] Acute stroke with high-dose intravenous immune globulin
    White, David A.
    Leonard, Mandy C.
    AMERICAN JOURNAL OF HEALTH-SYSTEM PHARMACY, 2007, 64 (15) : 1611 - 1614
  • [48] Accurate Prediction of Initial Busulfan Exposure Using a Test Dose With 2-and 6-Hour Blood Sampling in Adult Patients Receiving a Twice-Daily Intravenous Busulfan-Based Conditioning Regimen
    Huang, Jingjing
    Li, Ziwei
    Liang, Wu
    Chen, Bing
    Hu, Jiong
    Yang, Wanhua
    JOURNAL OF CLINICAL PHARMACOLOGY, 2019, 59 (05) : 638 - 645
  • [49] Busulfan plus melphalan versus high-dose melphalan as conditioning regimens in autologous stem cell transplantation for newly diagnosed multiple myeloma
    Byun, Ja Min
    Lee, Jayoun
    Shin, Sang-Jin
    Kang, Minjoo
    Yoon, Sung-Soo
    Koh, Youngil
    BLOOD RESEARCH, 2018, 53 (02) : 105 - 109
  • [50] FEASIBILITY OF SEQUENTIAL HIGH-DOSE CHEMOTHERAPY IN ADVANCED PEDIATRIC SOLID TUMORS
    Kwon, Seung Yeon
    Won, Sung Chul
    Han, Jung Woo
    Shin, Yoon Jung
    Lyu, Chuhl Joo
    PEDIATRIC HEMATOLOGY AND ONCOLOGY, 2010, 27 (01) : 1 - 12
12345